Gen‐27, a newly synthesized flavonoid, inhibits glycolysis and induces cell apoptosis via suppression of hexokinase II in human breast cancer cells

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Biochemical Pharmacology

• Publication date

  2017-02-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bcp.2016.11.001PMID 27818240
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficacy and safety of re-induction therapy with bevacizumab and paclitaxel for metastatic breast cancer

  2016cited by this paper
• Cancer statistics, 2016

  2016cited by this paper
• GEN-27, a Newly Synthetic Isoflavonoid, Inhibits the Proliferation of Colon Cancer Cells in Inflammation Microenvironment by Suppressing NF-κB Pathway

  2016cited by this paper
• Chemopreventive activity of GEN-27, a genistein derivative, in colitis-associated cancer is mediated by p65-CDX2-β-catenin axis

  2016cited by this paper
• FV‐429 induces apoptosis and inhibits glycolysis by inhibiting Akt‐mediated phosphorylation of hexokinase II in MDA‐MB‐231 cells

  2016cited by this paper
• Hexokinase II integrates energy metabolism and cellular protection: Akting on mitochondria and TORCing to autophagy

  2015cited by this paper
• Breast Cancer Metabolism and Mitochondrial Activity: The Possibility of Chemoprevention with Metformin

  2015influential reference
• Female breast cancer statistics of 2010 in China: estimates based on data from 145 population-based cancer registries.

  2014cited by this paper
• Mitochondrial function and energy metabolism in neuronal HT22 cells resistant to oxidative stress

  2014cited by this paper
• LL-202, a newly synthesized flavonoid, inhibits tumor growth via inducing G(2)/M phase arrest and cell apoptosis in MCF-7 human breast cancer cells in vitro and in vivo.

  2014cited by this paper
• Identification of LDH-A as a therapeutic target for cancer cell killing via (i) p53/NAD(H)-dependent and (ii) p53-independent pathways

  2014cited by this paper
• Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer.

  2013cited by this paper
• Hexokinase 2 as oncotarget

  2013cited by this paper
• Proviral Insertion in Murine Lymphomas 2 (PIM2) Oncogene Phosphorylates Pyruvate Kinase M2 (PKM2) and Promotes Glycolysis in Cancer Cells*

  2013cited by this paper
• Targeting VDAC-bound hexokinase II: a promising approach for concomitant anti-cancer therapy

  2013cited by this paper
• Akt Phosphorylates HK-II at Thr-473 and Increases Mitochondrial HK-II Association to Protect Cardiomyocytes

  2013cited by this paper
• Natural products: a continuing source of novel drug leads.

  2013cited by this paper
• Triptolide induces lysosomal-mediated programmed cell death in MCF-7 breast cancer cells

  2013cited by this paper
• Therapeutic targets in cancer cell metabolism and autophagy

  2012cited by this paper
• Mitochondrial VDAC1: function in cell life and death and a target for cancer therapy.

  2012cited by this paper
• Targeting cancer metabolism: a therapeutic window opens

  2011cited by this paper
• Flavonoids as Anticancer Agents: Recent Progress and State of the Art?

  2011cited by this paper
• Natural products for cancer chemotherapy

  2011cited by this paper
• Anticancer properties of flavonoids: roles in various stages of carcinogenesis.

  2011cited by this paper
• Cancer Chemoprevention by Natural Products: How Far Have We Come?

  2010cited by this paper
• Mitochondrial function and energy metabolism in cancer cells: past overview and future perspectives.

  2009cited by this paper
• Methyl jasmonate binds to and detaches mitochondria-bound hexokinase

  2008cited by this paper
• Regulation of hexokinase binding to VDAC

  2008cited by this paper
• Hexokinase II Detachment from Mitochondria Triggers Apoptosis through the Permeability Transition Pore Independent of Voltage-Dependent Anion Channels

  2008cited by this paper
• Voltage dependent anion channels (VDACs): a brief introduction with a focus on the outer mitochondrial compartment’s roles together with hexokinase-2 in the “Warburg effect” in cancer

  2008cited by this paper
• Tumor cell metabolism: cancer's Achilles' heel.

  2008cited by this paper
• Disruption of the hexokinase–VDAC complex for tumor therapy

  2008cited by this paper
• Glucose Phosphorylation and Mitochondrial Binding Are Required for the Protective Effects of Hexokinases I and II

  2007cited by this paper
• Apoptotic effect of 3,4‐dihydroxybenzoic acid on human gastric carcinoma cells involving JNK/p38 MAPK signaling activation

  2007cited by this paper
• Suppression of Apoptosis by Cyclophilin D via Stabilization of Hexokinase II Mitochondrial Binding in Cancer Cells*

  2006cited by this paper
• Mitochondrial hexokinases, novel mediators of the antiapoptotic effects of growth factors and Akt

  2006cited by this paper
• Reactive Oxygen Species Mediate Caspase Activation and Apoptosis Induced by Lipoic Acid in Human Lung Epithelial Cancer Cells through Bcl-2 Down-Regulation

  2006cited by this paper
• Plants as a source of anti-cancer agents.

  2005cited by this paper
• Phytoestrogens: End of a tale?

  2005cited by this paper
• Review Cell Death: Critical Control Points Another Line of Evidence for the Importance of Caspases in Cell Death Came From

  2004cited by this paper
• Cell death: critical control points.

  2004cited by this paper
• Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function

  2003cited by this paper
• Mitochondrial Binding of Hexokinase II Inhibits Bax-induced Cytochrome c Release and Apoptosis*

  2002cited by this paper
• Biologic correlates of (18)fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography.

  2002cited by this paper
• Biologic correlates of 18fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography

  2002cited by this paper
• Mitochondrial bound type II hexokinase: a key player in the growth and survival of many cancers and an ideal prospect for therapeutic intervention.

  2002cited by this paper
• Cooperation and Competition in the Evolution of ATP-Producing Pathways

  2001cited by this paper
• Caspase activation in response to cytotoxic Rana catesbeiana ribonuclease in MCF‐7 cells

  2001cited by this paper
• Mammalian hexokinases and their abnormal expression in cancer.

  2000cited by this paper
• Soy, its components, and cancer prevention: a review of the in vitro, animal, and human data.

  1998cited by this paper
• Cancer statistics

  1989cited by this paper
• Enzyme activities in normal, dysplastic, and cancerous human breast tissues.

  1984cited by this paper

• Metabolic reprogramming in cancer: signaling pathways and therapeutic targets.

  2026cites this paper
• Genistein in Triple‐Negative Breast Cancer: Anticancer Mechanisms and Structural Modifications

  2025cites this paper
• Warburg effect and lactylation in cancer: mechanisms for chemoresistance

  2025influential citation
• Lipidomics and metabolomics as potential biomarkers for breast cancer progression

  2024cites this paper
• Glycolysis, The Sweet Appetite of the Tumour Microenvironment.

  2024cites this paper
• Breast cancer therapy: from the perspective of glucose metabolism and glycosylation

  2024cites this paper
• Targeting the Metabolic Paradigms in Cancer and Diabetes

  2024cites this paper
• Biosafe cerium oxide nanozymes protect human pluripotent stem cells and cardiomyocytes from oxidative stress

  2024cites this paper
• Lactate and Lactylation: Dual Regulators of T-Cell-Mediated Tumor Immunity and Immunotherapy

  2024cites this paper
• Metabolic Reprogramming in Cancer: Implications for Immunosuppressive Microenvironment

  2024cites this paper
• Flavonoids attenuate cancer metabolism by modulating Lipid metabolism, amino acids, ketone bodies and redox state mediated by Nrf2.

  2023cites this paper
• Unmasking the Warburg Effect: Unleashing the Power of Enzyme Inhibitors for Cancer Therapy

  2023cites this paper
• Metabolic Alterations in Canine Mammary Tumors

  2023cites this paper
• Therapeutic Potential of Genistein and its Derivatives as a Target for Anticancer Agents

  2023cites this paper
• Signaling pathways in cancer metabolism: mechanisms and therapeutic targets

  2023cites this paper
• Small molecule inhibitors for cancer metabolism: promising prospects to be explored

  2023cites this paper
• Metabolic reprogramming in cancer: Mechanisms and therapeutics

  2023cites this paper
• Metabolomics in oncology

  2023cites this paper
• GENİŞ SPEKTRUMLU ANTİKANSER BİLEŞİKLER GELİŞTİRMEYE YÖNELİK POTANSİYEL BİR HEDEF: HEKSOKİNAZ-II

  2022cites this paper
• Intracellular Pathways and Mechanisms of Colored Secondary Metabolites in Cancer Therapy

  2022cites this paper
• Targeting Glucose Metabolism Enzymes in Cancer Treatment: Current and Emerging Strategies

  2022cites this paper
• Flavonoids for the treatment of breast cancer, present status and future prospective.

  2022cites this paper
• Overview of Cancer Metabolism and Signaling Transduction

  2022cites this paper
• Proteomics analysis of meclofenamic acid‐treated small cell lung carcinoma cells revealed changes in cellular energy metabolism for cancer cell survival

  2022cites this paper
• Cancer Stem Cells: Metabolic Characterization for Targeted Cancer Therapy

  2021cites this paper
• Flavonoids Targeting HIF-1: Implications on Cancer Metabolism

  2021influential citation
• Research progress of nanocarriers for gene therapy targeting abnormal glucose and lipid metabolism in tumors

  2021cites this paper
• Aberrant Metabolism as Inductor of Epigenetic Changes in Breast Cancer: Therapeutic Opportunities

  2021cites this paper
• Bioactive Natural Leads Targeting Cancer Cell Metabolism

  2021cites this paper
• Mechanisms of Metabolic Reprogramming in Cancer Cells Supporting Enhanced Growth and Proliferation

  2021cites this paper
• Discovery and development of tumor glycolysis rate-limiting enzyme inhibitors.

  2021cites this paper
• Flavonoids against the Warburg phenotype—concepts of predictive, preventive and personalised medicine to cut the Gordian knot of cancer cell metabolism

  2020influential citation
• Non-coding RNAs: emerging regulators of glucose metabolism in hepatocellular carcinoma.

  2020cites this paper
• Glycolytic inhibition: an effective strategy for developing calorie restriction mimetics

  2020cites this paper
• Energy metabolism in cancer stem cells.

  2020cites this paper
• Lactate Dehydrogenase Inhibition With Oxamate Exerts Bone Anabolic Effect

  2020cites this paper
• FB-15 inhibits MGC-803 cells growth by regulating energy metabolism.

  2020cites this paper
• FS-7 inhibits MGC-803 cells growth in vitro and in vivo via down-regulating glycolysis.

  2019cites this paper
• Targeting glucose metabolism to suppress cancer progression: prospective of anti-glycolytic cancer therapy.

  2019cites this paper
• Emerging roles of aerobic glycolysis in breast cancer

  2019cites this paper
• Design, synthesis, and preliminary biological evaluation of 3′,4′,5′-trimethoxy flavonoid salicylate derivatives as potential anti-tumor agents

  2019cites this paper
• Design, synthesis and biological evaluation of tryptamine salicylic acid derivatives as potential antitumor agents.

  2019cites this paper
• Epistructured catechins, EGCG and EC facilitate apoptosis induction through targeting de novo lipogenesis pathway in HepG2 cells

  2018cites this paper
• Targeting Tumor Metabolism with Plant-Derived Natural Products: Emerging Trends in Cancer Therapy.

  2018cites this paper
• Inhibition of Glycolysis and Glutaminolysis: An Emerging Drug Discovery Approach to Combat Cancer

  2018cites this paper
• MiR-125b-5p suppressed the glycolysis of laryngeal squamous cell carcinoma by down-regulating hexokinase-2.

  2018cites this paper
• Exploitation of new chalcones and 4H-chromenes as agents for cancer treatment.

  2018cites this paper
• Selective anticancer activity of the novel steroidal dihydropyridine spirooxindoles against human esophageal EC109 cells.

  2017cites this paper